Post Content
-
International smoke-free performance was the primary growth engine, driven by IQOS momentum and multi-category expansion with ZYN and VEEV reaching joint #1 positions in Europe.
-
Combustible business resilience was maintained through robust pricing power, specifically an 8.5% increase, which successfully offset volume declines at the high end of expectations.
-
U.S. ZYN performance faced temporary shipment challenges due to the normalization of a 25 million can channel inventory overhang from late 2025 and a difficult comparison to a low-promotion prior year.
-
Operational efficiency remained a focus with approximately $150 million in gross cost savings realized in Q1 to support continued reinvestment in smoke-free innovation.
-
The company successfully captured over 70% of industry smoke-free growth in markets where it competes, demonstrating the scale advantages of its multi-category portfolio.
-
Market-specific headwinds in cigarettes were attributed to excise tax increases in Mexico and India, alongside a challenging economic environment fueling illicit consumption.
-
Management expects U.S. performance to progressively improve in the second half of 2026 as comparisons normalize and new ZYN innovations are launched.
-
Full-year cigarette volume declines are forecasted to moderate to around 3% as temporary inventory and excise-driven impacts from Q1 begin to ease.
-
The company is preparing for the U.S. launch of ZYN Ultra and IQOS ILUMA, pending ongoing regulatory dialogues and FDA authorization processes.
-
SG&A investment is expected to remain high in Q2 to support commercial scaling but will moderate in the second half to align with organic net revenue growth.
-
Guidance for 2026 assumes a $0.25 currency tailwind at prevailing rates, supporting an updated adjusted diluted EPS forecast of $8.36 to $8.51.
-
The Middle East conflict caused minor disruptions to Global Travel Retail and regional shipments, though it has not yet significantly altered consumer behavior.
-
A consumer pantry loading benefit of approximately 0.5 billion units in Japan ahead of April excise increases will likely reverse in Q2 results.
-
The implementation of the EU characterizing flavor ban in markets like Poland and Hungary created initial volume disruption for IQOS, though recovery is expected based on trends in Italy.
-
Underage usage of nicotine pouches remains a key regulatory focus, though management cited survey data showing stable or declining usage levels below 2%.
Terms and Privacy Policy